Celldex Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $90M | 3.3M | 27.52 |
| 2023-06-30 | $109M | 3.2M | 33.93 |
| 2023-03-31 | $117M | 3.3M | 35.98 |
| 2022-12-31 | $144M | 3.2M | 44.57 |
| 2022-06-30 | $85M | 3.2M | 26.95 |
| 2021-06-30 | $90M | 2.7M | 33.45 |
| 2021-03-31 | $20M | 968k | 20.64 |
| 2020-12-31 | $15M | 861k | 17.56 |
| 2020-09-30 | $12M | 792k | 14.84 |
| 2020-03-31 | $602k | 345k | 1.75 |
| 2019-12-31 | $722k | 342k | 2.11 |
| 2019-09-30 | $723k | 343k | 2.11 |
| 2019-06-30 | $958k | 341k | 2.81 |
| 2019-03-31 | $0 | 303k | 0.00 |